Formation and Purpose. Within [***] ([***]) days after the Effective Date, the Parties shall establish a joint manufacturing committee (the “JMC”) which will have strategic oversight of the manufacture and distribution of the Products including receiving updates from Orexigen regarding the Third Party Manufacturers, and monitoring the production capabilities of the Third Party Manufacturers in order that Takeda may forecast when Takeda demand for the Products in a given [***] exceed (or are likely to exceed) the maximum production capability of the Third Party Manufacturers in such [***] and overseeing the arrangements for the distribution of Products which are to be delivered as specified on the relevant binding order.
Appears in 3 contracts
Samples: Co Development, Co Promotion, Marketing and Licensing Agreement, Co Development, Co Promotion, Marketing and Licensing Agreement, Collaboration Agreement (Orexigen Therapeutics, Inc.)
Formation and Purpose. Within […***…] ([…***]) …] days after the Original Effective Date, the Parties shall establish a joint manufacturing committee (the “JMC”) which will have strategic oversight of the manufacture and distribution of the Products in and for the Territory, including receiving updates from Orexigen regarding the Third Party Manufacturers, and monitoring the production capabilities of the Third Party Manufacturers in order that Takeda may forecast when Takeda demand for the Products in a given […***…] exceed (or are likely to exceed) the maximum production capability of the Third Party Manufacturers in such […***] …]; and overseeing the arrangements for the distribution of Products which are to be delivered as specified on the relevant binding order.
Appears in 1 contract
Samples: Collaboration Agreement (Orexigen Therapeutics, Inc.)
Formation and Purpose. Within [***] fifteen ([***]15) days after the Original Effective Date, the Parties shall establish a joint manufacturing committee (the “JMC”) which will have strategic oversight of the manufacture and distribution of the Products in and for the Territory, including receiving updates from Orexigen regarding the Third Party Manufacturers, and monitoring the production capabilities of the Third Party Manufacturers in order that Takeda may forecast when Takeda demand for the Products in a given [***] Calendar Quarter exceed (or are likely to exceed) the maximum production capability of the Third Party Manufacturers in such [***] Calendar Quarter; and overseeing the arrangements for the distribution of Products which are to be delivered as specified on the relevant binding order.
Appears in 1 contract
Samples: Collaboration Agreement (Orexigen Therapeutics, Inc.)
